English

VAXCYTE, INC.

EDGAR

PCVX Quarterly report (10-Q) · filed 2026-08-05

31 filing records in this dataset, filed from 2020-05-22 to 2026-08-05. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Cash and cash equivalents: 183 million USD 2026-06-30 Source
Exact value

183190000 USD
Long-term debt including current maturities: Not available
Shares outstanding: 145 million shares 2026-06-30 Source
Exact value

144785934 shares

Reported share-count change

11.53% · 15 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

129816472 shares · 2025-06-30· Source
144785934 shares · 2026-06-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Net income

-1.06 billion USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Net income: -212830000 USD · 2025-07-01 – 2025-09-30 Source
Net income: -766628000 USD · 2025-01-01 – 2025-12-31 Source
Net income: -520121000 USD · 2025-01-01 – 2025-09-30 Source
Net income: -320622000 USD · 2026-01-01 – 2026-03-31 Source
Net income: -284302000 USD · 2026-04-01 – 2026-06-30 Source

Operating cash flow

-881 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Operating cash flow: -430745000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -287440000 USD · 2025-01-01 – 2025-06-30 Source
Operating cash flow: -655577000 USD · 2025-01-01 – 2025-12-31 Source
Operating cash flow: -430745000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -280625000 USD · 2026-01-01 – 2026-03-31 Source
Operating cash flow: -513096000 USD · 2026-01-01 – 2026-06-30 Source
Operating cash flow: -280625000 USD · 2026-01-01 – 2026-03-31 Source

Capital expenditure

12.9 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Capital expenditure: 11059000 USD · 2025-01-01 – 2025-09-30 Source
Capital expenditure: 7235000 USD · 2025-01-01 – 2025-06-30 Source
Capital expenditure: 13713000 USD · 2025-01-01 – 2025-12-31 Source
Capital expenditure: 11059000 USD · 2025-01-01 – 2025-09-30 Source
Capital expenditure: 2107000 USD · 2026-01-01 – 2026-03-31 Source
Capital expenditure: 6426000 USD · 2026-01-01 – 2026-06-30 Source
Capital expenditure: 2107000 USD · 2026-01-01 – 2026-03-31 Source

Free cash flow

-894 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Operating cash flow: -430745000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -287440000 USD · 2025-01-01 – 2025-06-30 Source
Operating cash flow: -655577000 USD · 2025-01-01 – 2025-12-31 Source
Operating cash flow: -430745000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -280625000 USD · 2026-01-01 – 2026-03-31 Source
Operating cash flow: -513096000 USD · 2026-01-01 – 2026-06-30 Source
Operating cash flow: -280625000 USD · 2026-01-01 – 2026-03-31 Source
Capital expenditure: 11059000 USD · 2025-01-01 – 2025-09-30 Source
Capital expenditure: 7235000 USD · 2025-01-01 – 2025-06-30 Source
Capital expenditure: 13713000 USD · 2025-01-01 – 2025-12-31 Source
Capital expenditure: 11059000 USD · 2025-01-01 – 2025-09-30 Source
Capital expenditure: 2107000 USD · 2026-01-01 – 2026-03-31 Source
Capital expenditure: 6426000 USD · 2026-01-01 – 2026-06-30 Source
Capital expenditure: 2107000 USD · 2026-01-01 – 2026-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-08-05.

Financial data available through: 2025-12-31.

Coverage by financial measure

revenue: No compatible figures in this window
Operating income: 8 of 11 periods available· newest 2025-12-31
Net income: 8 of 11 periods available· newest 2025-12-31
Operating cash flow: 8 of 11 periods available· newest 2025-12-31
Capital expenditure: 8 of 11 periods available· newest 2025-12-31
Total assets: 7 of 11 periods available· newest 2025-12-31
Total liabilities: 7 of 11 periods available· newest 2025-12-31
Current assets: 7 of 11 periods available· newest 2025-12-31
Current liabilities: 7 of 11 periods available· newest 2025-12-31
Cash and cash equivalents: 7 of 11 periods available· newest 2025-12-31
long term debt: No compatible figures in this window
Shares outstanding: 7 of 11 periods available· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Net income
−USD 302.7 million

Prior period

−USD 463.93 million

2024-01-01 – 2024-12-31
Current period

−USD 766.63 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-766628000 − -463927000 = -302701000 USD

-463927000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-766628000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · VAXCYTE, INC. · 2025-12-31 VAXCYTE, INC. (edgar:1649094) Year-over-year change in Net income: -302701000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T16:41:06Z Snapshot: 59989618484b8ba9dee0298ab2ee330b49d035d275be26b9ec0f5bed8d8dca37 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1649094?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -766628000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1649094/000164909426000007/pcvx-20251231.htm#1531914 Filing: 000164909426000007 Input fundies:NetIncome: -463927000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1649094/000164909426000007/pcvx-20251231.htm#1509024 Filing: 000164909426000007
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 202.95 million

Prior period

−USD 452.63 million

2024-01-01 – 2024-12-31
Current period

−USD 655.58 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-655577000 − -452627000 = -202950000 USD

-452627000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-655577000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · VAXCYTE, INC. · 2025-12-31 VAXCYTE, INC. (edgar:1649094) Year-over-year change in Operating cash flow: -202950000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T16:41:06Z Snapshot: 59989618484b8ba9dee0298ab2ee330b49d035d275be26b9ec0f5bed8d8dca37 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1649094?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -655577000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1649094/000164909426000007/pcvx-20251231.htm#1572892 Filing: 000164909426000007 Input fundies:OperatingCashFlow: -452627000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1649094/000164909426000007/pcvx-20251231.htm#1573544 Filing: 000164909426000007
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-38.9%

Prior period

USD 22.43 million

2024-01-01 – 2024-12-31
Current period

USD 13.71 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

13713000 − 22427000 = -8714000 USD

22427000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
13713000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · VAXCYTE, INC. · 2025-12-31 VAXCYTE, INC. (edgar:1649094) Year-over-year change in Capital expenditure: -8714000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T16:41:06Z Snapshot: 59989618484b8ba9dee0298ab2ee330b49d035d275be26b9ec0f5bed8d8dca37 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1649094?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 13713000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1649094/000164909426000007/pcvx-20251231.htm#1575709 Filing: 000164909426000007 Input fundies:CapitalExpenditure: 22427000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1649094/000164909426000007/pcvx-20251231.htm#1576299 Filing: 000164909426000007
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

Revenue is not reported for this company, so its costs cannot be shown as a share of it.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

Not enough comparable data to show this history.

Values and sources

Revenue values and source evidence
Period	Series	Value	Source evidence

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Not enough comparable data to show this history.

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence

Operating cash flow

Cash generated by the company’s normal business operations.

Not enough comparable data to show this history.

Values and sources

Operating cash flow values and source evidence
Period	Series	Value	Source evidence

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence

Current assets to current liabilities

Current assets divided by current liabilities.

Not enough comparable data to show this history.

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2018 2018-01-01 – 2018-12-31	−USD 29.49 million Exact value Exact value: -29485000 USD 2018-01-01 – 2018-12-31: -29485000 USD Inspect Net Income Open source Share or cite Citation for Net Income · VAXCYTE, INC. · 2018-12-31 VAXCYTE, INC. (edgar:1649094) Net Income: -29485000 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T16:41:06Z Snapshot: 59989618484b8ba9dee0298ab2ee330b49d035d275be26b9ec0f5bed8d8dca37 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1649094/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -29485000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1649094/000156459021016110/pcvx-10k_20201231.htm#2318437 Filing: 000156459021016110 The citation records this snapshot. The page link may show a newer release later.	−USD 30.47 million Exact value Exact value: -30466000 USD 2018-01-01 – 2018-12-31: -30466000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · VAXCYTE, INC. · 2018-12-31 VAXCYTE, INC. (edgar:1649094) Operating Cash Flow: -30466000 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T16:41:06Z Snapshot: 59989618484b8ba9dee0298ab2ee330b49d035d275be26b9ec0f5bed8d8dca37 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1649094/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -30466000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1649094/000156459021016110/pcvx-10k_20201231.htm#2939244 Filing: 000156459021016110 The citation records this snapshot. The page link may show a newer release later.	USD 1.77 million Exact value Exact value: 1774000 USD 2018-01-01 – 2018-12-31: 1774000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · VAXCYTE, INC. · 2018-12-31 VAXCYTE, INC. (edgar:1649094) Capital Expenditure: 1774000 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T16:41:06Z Snapshot: 59989618484b8ba9dee0298ab2ee330b49d035d275be26b9ec0f5bed8d8dca37 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1649094/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1774000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1649094/000156459021016110/pcvx-10k_20201231.htm#2950292 Filing: 000156459021016110 The citation records this snapshot. The page link may show a newer release later.	−USD 32.24 million Calculation and evidence -30466000 − 1774000 USD Exact free cash flow: -32240000 USD 2018-01-01 – 2018-12-31: -30466000 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 1774000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · VAXCYTE, INC. · 2018-12-31 VAXCYTE, INC. (edgar:1649094) Free cash flow: -32240000 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T16:41:06Z Snapshot: 59989618484b8ba9dee0298ab2ee330b49d035d275be26b9ec0f5bed8d8dca37 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1649094?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -30466000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1649094/000156459021016110/pcvx-10k_20201231.htm#2939244 Filing: 000156459021016110 Input fundies:CapitalExpenditure: 1774000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1649094/000156459021016110/pcvx-10k_20201231.htm#2950292 Filing: 000156459021016110 The citation records this snapshot. The page link may show a newer release later.
2019 2019-01-01 – 2019-12-31	−USD 50.27 million Exact value Exact value: -50274000 USD 2019-01-01 – 2019-12-31: -50274000 USD Inspect Net Income Open source Share or cite Citation for Net Income · VAXCYTE, INC. · 2019-12-31 VAXCYTE, INC. (edgar:1649094) Net Income: -50274000 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T16:41:06Z Snapshot: 59989618484b8ba9dee0298ab2ee330b49d035d275be26b9ec0f5bed8d8dca37 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1649094/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -50274000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1649094/000095017022002281/pcvx-20211231.htm#2304867 Filing: 000095017022002281 The citation records this snapshot. The page link may show a newer release later.	−USD 47.15 million Exact value Exact value: -47145000 USD 2019-01-01 – 2019-12-31: -47145000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · VAXCYTE, INC. · 2019-12-31 VAXCYTE, INC. (edgar:1649094) Operating Cash Flow: -47145000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T16:41:06Z Snapshot: 59989618484b8ba9dee0298ab2ee330b49d035d275be26b9ec0f5bed8d8dca37 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1649094/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -47145000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1649094/000095017022002281/pcvx-20211231.htm#2980755 Filing: 000095017022002281 The citation records this snapshot. The page link may show a newer release later.	USD 1.2 million Exact value Exact value: 1195000 USD 2019-01-01 – 2019-12-31: 1195000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · VAXCYTE, INC. · 2019-12-31 VAXCYTE, INC. (edgar:1649094) Capital Expenditure: 1195000 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T16:41:06Z Snapshot: 59989618484b8ba9dee0298ab2ee330b49d035d275be26b9ec0f5bed8d8dca37 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1649094/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1195000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1649094/000095017022002281/pcvx-20211231.htm#2990979 Filing: 000095017022002281 The citation records this snapshot. The page link may show a newer release later.	−USD 48.34 million Calculation and evidence -47145000 − 1195000 USD Exact free cash flow: -48340000 USD 2019-01-01 – 2019-12-31: -47145000 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 1195000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · VAXCYTE, INC. · 2019-12-31 VAXCYTE, INC. (edgar:1649094) Free cash flow: -48340000 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T16:41:06Z Snapshot: 59989618484b8ba9dee0298ab2ee330b49d035d275be26b9ec0f5bed8d8dca37 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1649094?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -47145000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1649094/000095017022002281/pcvx-20211231.htm#2980755 Filing: 000095017022002281 Input fundies:CapitalExpenditure: 1195000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1649094/000095017022002281/pcvx-20211231.htm#2990979 Filing: 000095017022002281 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	−USD 89.22 million Exact value Exact value: -89217000 USD 2020-01-01 – 2020-12-31: -89217000 USD Inspect Net Income Open source Share or cite Citation for Net Income · VAXCYTE, INC. · 2020-12-31 VAXCYTE, INC. (edgar:1649094) Net Income: -89217000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T16:41:06Z Snapshot: 59989618484b8ba9dee0298ab2ee330b49d035d275be26b9ec0f5bed8d8dca37 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1649094/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -89217000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1649094/000095017023004654/pcvx-20221231.htm#2860563 Filing: 000095017023004654 The citation records this snapshot. The page link may show a newer release later.	−USD 46.63 million Exact value Exact value: -46628000 USD 2020-01-01 – 2020-12-31: -46628000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · VAXCYTE, INC. · 2020-12-31 VAXCYTE, INC. (edgar:1649094) Operating Cash Flow: -46628000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T16:41:06Z Snapshot: 59989618484b8ba9dee0298ab2ee330b49d035d275be26b9ec0f5bed8d8dca37 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1649094/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -46628000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1649094/000095017023004654/pcvx-20221231.htm#3525464 Filing: 000095017023004654 The citation records this snapshot. The page link may show a newer release later.	USD 1.16 million Exact value Exact value: 1155000 USD 2020-01-01 – 2020-12-31: 1155000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · VAXCYTE, INC. · 2020-12-31 VAXCYTE, INC. (edgar:1649094) Capital Expenditure: 1155000 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T16:41:06Z Snapshot: 59989618484b8ba9dee0298ab2ee330b49d035d275be26b9ec0f5bed8d8dca37 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1649094/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1155000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1649094/000095017023004654/pcvx-20221231.htm#3536823 Filing: 000095017023004654 The citation records this snapshot. The page link may show a newer release later.	−USD 47.78 million Calculation and evidence -46628000 − 1155000 USD Exact free cash flow: -47783000 USD 2020-01-01 – 2020-12-31: -46628000 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 1155000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · VAXCYTE, INC. · 2020-12-31 VAXCYTE, INC. (edgar:1649094) Free cash flow: -47783000 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T16:41:06Z Snapshot: 59989618484b8ba9dee0298ab2ee330b49d035d275be26b9ec0f5bed8d8dca37 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1649094?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -46628000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1649094/000095017023004654/pcvx-20221231.htm#3525464 Filing: 000095017023004654 Input fundies:CapitalExpenditure: 1155000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1649094/000095017023004654/pcvx-20221231.htm#3536823 Filing: 000095017023004654 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	−USD 100.08 million Exact value Exact value: -100077000 USD 2021-01-01 – 2021-12-31: -100077000 USD Inspect Net Income Open source Share or cite Citation for Net Income · VAXCYTE, INC. · 2021-12-31 VAXCYTE, INC. (edgar:1649094) Net Income: -100077000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T16:41:06Z Snapshot: 59989618484b8ba9dee0298ab2ee330b49d035d275be26b9ec0f5bed8d8dca37 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1649094/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -100077000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1649094/000095017024021145/pcvx-20231231.htm#2138962 Filing: 000095017024021145 The citation records this snapshot. The page link may show a newer release later.	−USD 121.39 million Exact value Exact value: -121393000 USD 2021-01-01 – 2021-12-31: -121393000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · VAXCYTE, INC. · 2021-12-31 VAXCYTE, INC. (edgar:1649094) Operating Cash Flow: -121393000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T16:41:06Z Snapshot: 59989618484b8ba9dee0298ab2ee330b49d035d275be26b9ec0f5bed8d8dca37 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1649094/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -121393000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1649094/000095017024021145/pcvx-20231231.htm#2390739 Filing: 000095017024021145 The citation records this snapshot. The page link may show a newer release later.	USD 6.56 million Exact value Exact value: 6555000 USD 2021-01-01 – 2021-12-31: 6555000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · VAXCYTE, INC. · 2021-12-31 VAXCYTE, INC. (edgar:1649094) Capital Expenditure: 6555000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T16:41:06Z Snapshot: 59989618484b8ba9dee0298ab2ee330b49d035d275be26b9ec0f5bed8d8dca37 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1649094/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 6555000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1649094/000095017024021145/pcvx-20231231.htm#2397696 Filing: 000095017024021145 The citation records this snapshot. The page link may show a newer release later.	−USD 127.95 million Calculation and evidence -121393000 − 6555000 USD Exact free cash flow: -127948000 USD 2021-01-01 – 2021-12-31: -121393000 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 6555000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · VAXCYTE, INC. · 2021-12-31 VAXCYTE, INC. (edgar:1649094) Free cash flow: -127948000 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T16:41:06Z Snapshot: 59989618484b8ba9dee0298ab2ee330b49d035d275be26b9ec0f5bed8d8dca37 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1649094?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -121393000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1649094/000095017024021145/pcvx-20231231.htm#2390739 Filing: 000095017024021145 Input fundies:CapitalExpenditure: 6555000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1649094/000095017024021145/pcvx-20231231.htm#2397696 Filing: 000095017024021145 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	−USD 223.49 million Exact value Exact value: -223485000 USD 2022-01-01 – 2022-12-31: -223485000 USD Inspect Net Income Open source Share or cite Citation for Net Income · VAXCYTE, INC. · 2022-12-31 VAXCYTE, INC. (edgar:1649094) Net Income: -223485000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T16:41:06Z Snapshot: 59989618484b8ba9dee0298ab2ee330b49d035d275be26b9ec0f5bed8d8dca37 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1649094/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -223485000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1649094/000164909425000028/pcvx-20241231.htm#1465164 Filing: 000164909425000028 The citation records this snapshot. The page link may show a newer release later.	−USD 170.6 million Exact value Exact value: -170597000 USD 2022-01-01 – 2022-12-31: -170597000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · VAXCYTE, INC. · 2022-12-31 VAXCYTE, INC. (edgar:1649094) Operating Cash Flow: -170597000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T16:41:06Z Snapshot: 59989618484b8ba9dee0298ab2ee330b49d035d275be26b9ec0f5bed8d8dca37 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1649094/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -170597000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1649094/000164909425000028/pcvx-20241231.htm#1565466 Filing: 000164909425000028 The citation records this snapshot. The page link may show a newer release later.	USD 5.84 million Exact value Exact value: 5841000 USD 2022-01-01 – 2022-12-31: 5841000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · VAXCYTE, INC. · 2022-12-31 VAXCYTE, INC. (edgar:1649094) Capital Expenditure: 5841000 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T16:41:06Z Snapshot: 59989618484b8ba9dee0298ab2ee330b49d035d275be26b9ec0f5bed8d8dca37 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1649094/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 5841000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1649094/000164909425000028/pcvx-20241231.htm#1568185 Filing: 000164909425000028 The citation records this snapshot. The page link may show a newer release later.	−USD 176.44 million Calculation and evidence -170597000 − 5841000 USD Exact free cash flow: -176438000 USD 2022-01-01 – 2022-12-31: -170597000 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 5841000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · VAXCYTE, INC. · 2022-12-31 VAXCYTE, INC. (edgar:1649094) Free cash flow: -176438000 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T16:41:06Z Snapshot: 59989618484b8ba9dee0298ab2ee330b49d035d275be26b9ec0f5bed8d8dca37 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1649094?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -170597000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1649094/000164909425000028/pcvx-20241231.htm#1565466 Filing: 000164909425000028 Input fundies:CapitalExpenditure: 5841000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1649094/000164909425000028/pcvx-20241231.htm#1568185 Filing: 000164909425000028 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	−USD 402.27 million Exact value Exact value: -402266000 USD 2023-01-01 – 2023-12-31: -402266000 USD Inspect Net Income Open source Share or cite Citation for Net Income · VAXCYTE, INC. · 2023-12-31 VAXCYTE, INC. (edgar:1649094) Net Income: -402266000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T16:41:06Z Snapshot: 59989618484b8ba9dee0298ab2ee330b49d035d275be26b9ec0f5bed8d8dca37 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1649094/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: -402266000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1649094/000164909426000007/pcvx-20251231.htm#1480420 Filing: 000164909426000007 The citation records this snapshot. The page link may show a newer release later.	−USD 296.79 million Exact value Exact value: -296790000 USD 2023-01-01 – 2023-12-31: -296790000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · VAXCYTE, INC. · 2023-12-31 VAXCYTE, INC. (edgar:1649094) Operating Cash Flow: -296790000 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T16:41:06Z Snapshot: 59989618484b8ba9dee0298ab2ee330b49d035d275be26b9ec0f5bed8d8dca37 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1649094/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -296790000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1649094/000164909426000007/pcvx-20251231.htm#1574196 Filing: 000164909426000007 The citation records this snapshot. The page link may show a newer release later.	USD 16.06 million Exact value Exact value: 16062000 USD 2023-01-01 – 2023-12-31: 16062000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · VAXCYTE, INC. · 2023-12-31 VAXCYTE, INC. (edgar:1649094) Capital Expenditure: 16062000 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T16:41:06Z Snapshot: 59989618484b8ba9dee0298ab2ee330b49d035d275be26b9ec0f5bed8d8dca37 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1649094/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 16062000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1649094/000164909426000007/pcvx-20251231.htm#1576889 Filing: 000164909426000007 The citation records this snapshot. The page link may show a newer release later.	−USD 312.85 million Calculation and evidence -296790000 − 16062000 USD Exact free cash flow: -312852000 USD 2023-01-01 – 2023-12-31: -296790000 USD · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 16062000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · VAXCYTE, INC. · 2023-12-31 VAXCYTE, INC. (edgar:1649094) Free cash flow: -312852000 USD Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T16:41:06Z Snapshot: 59989618484b8ba9dee0298ab2ee330b49d035d275be26b9ec0f5bed8d8dca37 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1649094?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -296790000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1649094/000164909426000007/pcvx-20251231.htm#1574196 Filing: 000164909426000007 Input fundies:CapitalExpenditure: 16062000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1649094/000164909426000007/pcvx-20251231.htm#1576889 Filing: 000164909426000007 The citation records this snapshot. The page link may show a newer release later.
2024 2024-01-01 – 2024-12-31	−USD 463.93 million Exact value Exact value: -463927000 USD 2024-01-01 – 2024-12-31: -463927000 USD Inspect Net Income Open source Share or cite Citation for Net Income · VAXCYTE, INC. · 2024-12-31 VAXCYTE, INC. (edgar:1649094) Net Income: -463927000 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T16:41:06Z Snapshot: 59989618484b8ba9dee0298ab2ee330b49d035d275be26b9ec0f5bed8d8dca37 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1649094/explain?concept=fundies%3ANetIncome&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:NetIncome: -463927000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1649094/000164909426000007/pcvx-20251231.htm#1509024 Filing: 000164909426000007 The citation records this snapshot. The page link may show a newer release later.	−USD 452.63 million Exact value Exact value: -452627000 USD 2024-01-01 – 2024-12-31: -452627000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · VAXCYTE, INC. · 2024-12-31 VAXCYTE, INC. (edgar:1649094) Operating Cash Flow: -452627000 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T16:41:06Z Snapshot: 59989618484b8ba9dee0298ab2ee330b49d035d275be26b9ec0f5bed8d8dca37 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1649094/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -452627000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1649094/000164909426000007/pcvx-20251231.htm#1573544 Filing: 000164909426000007 The citation records this snapshot. The page link may show a newer release later.	USD 22.43 million Exact value Exact value: 22427000 USD 2024-01-01 – 2024-12-31: 22427000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · VAXCYTE, INC. · 2024-12-31 VAXCYTE, INC. (edgar:1649094) Capital Expenditure: 22427000 USD Concept: fundies:CapitalExpenditure Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T16:41:06Z Snapshot: 59989618484b8ba9dee0298ab2ee330b49d035d275be26b9ec0f5bed8d8dca37 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1649094/explain?concept=fundies%3ACapitalExpenditure&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 22427000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1649094/000164909426000007/pcvx-20251231.htm#1576299 Filing: 000164909426000007 The citation records this snapshot. The page link may show a newer release later.	−USD 475.05 million Calculation and evidence -452627000 − 22427000 USD Exact free cash flow: -475054000 USD 2024-01-01 – 2024-12-31: -452627000 USD · Inspect Operating Cash Flow · Source 2024-01-01 – 2024-12-31: 22427000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · VAXCYTE, INC. · 2024-12-31 VAXCYTE, INC. (edgar:1649094) Free cash flow: -475054000 USD Concept: free-cash-flow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T16:41:06Z Snapshot: 59989618484b8ba9dee0298ab2ee330b49d035d275be26b9ec0f5bed8d8dca37 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1649094?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -452627000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1649094/000164909426000007/pcvx-20251231.htm#1573544 Filing: 000164909426000007 Input fundies:CapitalExpenditure: 22427000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1649094/000164909426000007/pcvx-20251231.htm#1576299 Filing: 000164909426000007 The citation records this snapshot. The page link may show a newer release later.
2025 2025-01-01 – 2025-12-31	−USD 766.63 million Exact value Exact value: -766628000 USD 2025-01-01 – 2025-12-31: -766628000 USD Inspect Net Income Open source Share or cite Citation for Net Income · VAXCYTE, INC. · 2025-12-31 VAXCYTE, INC. (edgar:1649094) Net Income: -766628000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T16:41:06Z Snapshot: 59989618484b8ba9dee0298ab2ee330b49d035d275be26b9ec0f5bed8d8dca37 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1649094/explain?concept=fundies%3ANetIncome&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:NetIncome: -766628000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1649094/000164909426000007/pcvx-20251231.htm#1531914 Filing: 000164909426000007 The citation records this snapshot. The page link may show a newer release later.	−USD 655.58 million Exact value Exact value: -655577000 USD 2025-01-01 – 2025-12-31: -655577000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · VAXCYTE, INC. · 2025-12-31 VAXCYTE, INC. (edgar:1649094) Operating Cash Flow: -655577000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T16:41:06Z Snapshot: 59989618484b8ba9dee0298ab2ee330b49d035d275be26b9ec0f5bed8d8dca37 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1649094/explain?concept=fundies%3AOperatingCashFlow&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -655577000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1649094/000164909426000007/pcvx-20251231.htm#1572892 Filing: 000164909426000007 The citation records this snapshot. The page link may show a newer release later.	USD 13.71 million Exact value Exact value: 13713000 USD 2025-01-01 – 2025-12-31: 13713000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · VAXCYTE, INC. · 2025-12-31 VAXCYTE, INC. (edgar:1649094) Capital Expenditure: 13713000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T16:41:06Z Snapshot: 59989618484b8ba9dee0298ab2ee330b49d035d275be26b9ec0f5bed8d8dca37 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1649094/explain?concept=fundies%3ACapitalExpenditure&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 13713000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1649094/000164909426000007/pcvx-20251231.htm#1575709 Filing: 000164909426000007 The citation records this snapshot. The page link may show a newer release later.	−USD 669.29 million Calculation and evidence -655577000 − 13713000 USD Exact free cash flow: -669290000 USD 2025-01-01 – 2025-12-31: -655577000 USD · Inspect Operating Cash Flow · Source 2025-01-01 – 2025-12-31: 13713000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · VAXCYTE, INC. · 2025-12-31 VAXCYTE, INC. (edgar:1649094) Free cash flow: -669290000 USD Concept: free-cash-flow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T16:41:06Z Snapshot: 59989618484b8ba9dee0298ab2ee330b49d035d275be26b9ec0f5bed8d8dca37 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1649094?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -655577000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1649094/000164909426000007/pcvx-20251231.htm#1572892 Filing: 000164909426000007 Input fundies:CapitalExpenditure: 13713000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1649094/000164909426000007/pcvx-20251231.htm#1575709 Filing: 000164909426000007 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

31 filings · 1,752 latest values · 1,752 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001649094, 1649094, PCVX, edgar:1649094

Also known as SutroVax, Inc., VAXCYTE, INC., Vaxcyte, Inc.

VAXCYTE, INC.

Reported share-count change

Trailing twelve months

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Net income

Operating cash flow

Capital expenditure

Where revenue goes

Growth

Profit and cash

Balance sheet

Cash generation